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E. Birgitte Lane2 and W.H. Irwin McLean1
Filaggrin is an abundant protein of the outer epidermis that is essential for terminal differentiation of
keratinocytes and formation of an effective barrier against water loss and pathogen/allergen/irritant invasion.
Recent investigations in Europe and Japan have revealed null mutations in the filaggrin gene (FLG) as the
underlying cause of ichthyosis vulgaris (IV), a common skin disorder characterised by dry skin, palmar
hyperlinearity and keratosis pilaris. Following the development of a strategy for the comprehensive analysis of
FLG, we have identified five unique mutations and one recurrent mutation in Singaporean Chinese IV patients.
Mutation 441delA is located in the profilaggrin S100 domain, whereas two additional frameshift mutations,
1249insG and 7945delA, occur in the first partial filaggrin repeat (‘‘repeat 0’’) and in filaggrin repeat 7,
respectively. Both nonsense mutations Q2147X and E2422X are found in filaggrin repeat 6, whereas R4307X was
found on one of the longer size variant alleles of FLG, within duplicated repeat 10.2. Mutation E2422X, previously
found in a single Dutch patient, was found in one Singaporean IV patient and at a low frequency in Asian
population controls. Our study confirms the presence of population-specific as well as recurrent FLG mutations
in Singapore.
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INTRODUCTION
Ichthyosis vulgaris (IV; OMIM #146700) is one of the most
common monogenic skin disorders, reported to affect 1 in
250 English school children (Wells, 1966). The disorder is
characterized by dry, scaly skin, palmar hyperlinearity, and
keratosis pilaris (Sybert et al., 1985; Smith et al., 2006), and
can be aggravated by climate. Other allergic conditions,
importantly including atopic dermatitis (AD), atopic asthma
and rhinitis, are also commonly manifested by IV patients
(Irvine and McLean, 2006; Irvine, 2007).
In 1985, Sybert et al. demonstrated that profilaggrin and
filaggrin were reduced or absent in five IV patients. The
filaggrin gene (FLG) is located on chromosome 1q21 within
a cluster of genes that make up the EDC—the epidermal
differentiation complex (Mischke et al., 1996). Profilaggrin
consists of three exons (Presland et al., 1992)—exon 1 (15 bp)
and exon 2 (159 bp) contain the 50-untranslated region and
start codon, respectively. Exon 3 is unusually large (12.7–
14.7 kb) and codes for most of the polyprotein profilaggrin,
which consists of 10–12 tandem repeats of the 37-kDa
filaggrin peptide. Profilaggrin is stored within keratohyalin
granules in the granular layer of the epidermis and proteo-
lytically cleaved to filaggrin subunits when keratinocytes
undergo terminal differentiation. Subsequently, filaggrin binds
to keratin intermediate filaments within the keratinocytes, as
the cells collapse and flatten into squames; transglutaminases
also work to cross-link other cornified envelope precursor
proteins such as involucrin to form an impermeable epidermal
barrier. It has also been shown that filaggrin subunits are
ultimately proteolyzed within the stratum corneum into
hygroscopic amino acids and derivatives thereof, which help
retain epidermal moisture (Rawlings and Harding, 2004).
Although filaggrin expression was known to be reduced
or absent in IV patients for 20 years, the route to uncovering
the direct genetic cause of IV was challenging because it
was very difficult to conduct routine and effective sequencing
of FLG due to its sheer size. The FLG gene is also highly repe-
titive and polymorphic, which prevents sequencing of the
entire gene by conventional methods. In 2006, the precise
molecular basis of IV was finally uncovered by the identi-
fication of null mutations in FLG (Smith et al., 2006). Since IV
was known to be associated with a high incidence of
AD (Kuokkanen, 1969; Tay et al., 2002), the link between
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filaggrin-null mutations and AD was quickly established
(Palmer et al., 2006). Reduced or absent filaggrin expression
chronically exposes the skin to irritants that can lead to
inflammation of skin, resulting in AD (Irvine, 2007). In some
populations, up to 50% of children with moderate to severe
AD carry FLG mutations and defects in FLG also predispose
AD patients to asthma and related allergic phenotypes (Irvine
and McLean, 2006).
This laboratory has recently reported methods for the
comprehensive analysis of FLG (Sandilands et al., 2007).
Three different sizes of FLG alleles were identified containing
10, 11, or 12 filaggrin repeats. By overlapping PCR and
unidirectional deletion strategies, FLG was fully sequenced,
and a total of 15 null mutations in FLG in the European,
Japanese and Chinese populations have been identified
to date (Nomura et al., 2007; Sandilands et al., 2007).
Interestingly, common mutations in the European population
differ from those in the Oriental populations studied so far.
Singapore is an immigrant South-East Asian city-state with
a population of 4.5 million consisting of Chinese (75.6%),
Malays (13.6%), Indians (8.7%), and other ethnic groups
(2.1%). The 1-year prevalence of IV in 2002 was reported
to be 8% in Singaporean school children (Tay et al., 2002).
Similar to many developed European countries, AD cases are
also on the rise in Singapore; a study conducted on 2,363
students in 2002 reported a prevalence of 20.8% (Tay et al.,
2002). In this study, we aimed to identify the FLG mutations
that underlie IV in this Asian population to facilitate future
studies of AD in this geographical region.
RESULTS
Case reports
All patients, adults of Chinese Singaporean ethinicity,
were referred to outpatient dermatological clinics at the
National Skin Centre, Singapore for the main complaint of
dry skin, with varying accompanying symptoms of eczema.
The diagnosis of IV was established on the clinical basis of
finding extensive semi-adherent scaling, which was charac-
teristic, a history of onset early in life; as well as a positive
family history of a similar affliction. These criteria were
chosen to increase the yield of a positive result on genetic
testing. Palmar hyperlinearity was seen in all patients
(Figure 1, Figure S1). Interestingly, keratosis pilaris was not
seen at all. IV was graded in terms of severe or mild, based on
the degree and extent (acral and truncal sites versus acral sites
only respectively) of scaling (Figure 1). Four out of six patients
with severe IV also had AD based on the widely recognized
diagnostic criteria (Hannifin and Rajka, 1980). None of the
patients with mild IV had active AD. All subjects were
examined by a single dermatologist.
Unique FLG mutations in Singaporean Chinese IV patients
We carried out full sequencing of the FLG in eight unrelated
Singaporean Chinese IV patients and detected mutations in
six individuals (Figures 3 and 4). A total of six mutations were
detected (Table 2)—five mutations are previously unreported
and one mutation was identified in a single Dutch IV patient
from an earlier study (Sandilands et al., 2007).
We identified a mutation within the S100 domain of
profilaggrin, 441delA, which was detected in patient 8 and
resulted in the introduction of a premature stop codon at
position 193. In patients 5 and 8, mutation 1249insG was
found in the first partial filaggrin repeat (termed ‘‘repeat 0’’)
preceding the first complete filaggrin repeat, leading to a
downstream premature stop codon at position 418. In repeat
6, two different nonsense mutations were detected in patients
4 and 6. Mutation E2422X and Q2417X mutations resulted
from a single nucleotide base substitution of G4T or C4T at
positions 7,249 and 7,264, respectively. Interestingly, muta-
tion E2422X was previously reported in a Dutch IV patient
(Sandilands et al., 2007) and we also detected one hetero-
zygous carrier in a cohort of 164 normal controls from China.
Frameshift mutation 7945delA was detected in filaggrin
repeat 7 in patients 3 and 5. Patient 2 harbored a nonsense
mutation in repeat 10.2, the first mutation to be reported in
one of the duplicated repeats found within the longer size
variant alleles of FLG (Sandilands et al., 2007). All mutations
were confirmed by direct sequencing of PCR products.
In addition, we further confirmed the presence of frame-
shift mutations (441delA, 1249insG, 7945delA) by sizing of
fluorescently labeled PCR products and the three nonsense
mutations (Q2417X, E2422X, R4307X) were also confirmed
a
c d
b
Mild IV Severe IV
Mild IV Severe IV
Figure 1. Clinical features of patients with IV. (a) Palmar hyperlinearity
seen in patient 3 heterozygous for FLG mutation 7945delA. (b) Due to the
semi-dominant inheritance pattern of IV, a more marked hyperlinearity can
be seen on the palms of patient 8, who is a compound heterozygote for
FLG mutations 441delA and 1249delG. (c) Fine scaling on limbs was also
present in patient 3. (d) In contrast, prominent scaling on the trunk and
limbs was seen in patients diagnosed with severe IV.
1670 Journal of Investigative Dermatology (2008), Volume 128
H Chen et al.
Mutations in Singaporean Chinese Patients with Ichthyosis Vulgaris
by restriction digestion of PCR products. No FLG mutations
were found in patients 1 and 7 (Table 2).
Screening of 100 Singaporean and 160 Chinese normal
controls for the six mutations identified in Singaporean
Chinese IV patients was also performed. With the exception
of one case of E2422X found in a Chinese control, none of the
other mutations were detected in the controls.
Absent or reduced profilaggrin expression in IV patients
Preliminary analysis of skin biopsies from all eight patients
was conducted using hematoxylin and eosin staining.
The appearance of keratohyalin granules was greatly reduced
in the granular layer of all patients except patient 1 (Figure 2).
To detect a change in filaggrin levels, we carried out
immunohistochemical analysis of the skin biopsies with
monoclonal antibody 15C10, which identifies an epitope
conserved in all or most filaggrin repeats. Filaggrin staining in
Patient 1 was comparable to that of normal skin (not shown).
In contrast, filaggrin staining was greatly reduced in patients
2, 3, 4, and 6; barely detectable staining was observed in
patients 5 and 8 (Figure 2), and staining was completely
absent in patient 7 (not shown).
DISCUSSION
Profilaggrin is an unusually large (12.7–14.7 kb) and repetitive
gene that has proved to be very challenging to sequence for
detection of pathogenic mutations. Recently, comprehensive
re-sequencing primers have been developed to allow
complete routine analysis of the entire FLG (Sandilands
et al., 2007).
In this report, we detected six mutations in Singaporean
Chinese IV patients, of which five have not been seen in
other populations previously studied (Gruber et al., 2006;
Marenholz et al., 2006; Smith et al., 2006; Barker et al., 2007;
Nomura et al., 2007; Sandilands et al., 2007; Stemmler et al.,
2007). Given the similar ancestry among the Singaporean
Chinese, Chinese, and Japanese, we were surprised that
the mutations previously detected in those populations were
not found in our study cohort. The Chinese and Japanese
populations share a common mutation 3321delA that is
absent in the European population but interestingly, this was
not found in our Singaporean Chinese patients despite being
found in 3.6% of Chinese controls (Sandilands et al., 2007). It
may be that this mutation is less common in Southern Asian
populations. With the known mutations now numbering
more than 20, it is possible that FLG is constantly under
evolutionary mutation pressure, so that every population will
have a unique set of FLG mutations.
The five unique mutations reported here were not detected
in any of the 260 normal control samples, therefore these
mutations are probably rare. This could also explain why
these mutations were not previously reported in the Japanese
and Chinese patients studied previously (Nomura et al.,
2007; Sandilands et al., 2007). Alternatively, these mutations
may also have arisen quite recently amongst the Singaporean
Chinese. Interestingly, both the 1249insG and 7945delA
frameshift mutations were detected in two out of eight
unrelated IV patients; therefore, a larger cohort of IV patients
will be useful in assessing the prevalence of these mutations
in Singaporean Chinese IV patients. It will also be of consi-
derable interest to screen Singaporean and Chinese AD case
series for the presence of these mutations as well as those
previously shown to be prevalent in other Asian populations
(Nomura et al., 2007; Sandilands et al., 2007); however, we
do not currently have access to such a study cohort.
Mutation E2422X was first reported in a Dutch IV patient
(Sandilands et al., 2007). It is intriguing to find the identical
mutation in a Singaporean Chinese patient as well as a single
case in a Chinese control individual. As this mutation was
not detected in other European populations nor was it
recurrent in the Dutch, it was classified as a rare mutation.
Upon further investigation, we were able to identify Chinese
ancestry in the Dutch IV patient. Therefore, our present data
H&E staining Filaggrin staining
Normal skin
7945delA heterozygote
441delA/1249insG 
compound heterozygote
Figure 2. Histological features of patients with IV. All left panels
show hematoxylin and eosin (H&E) staining and right panels show
immunohistochemical staining with the 15C10 monoclonal antibody against
filaggrin repeats in skin biopsies. (a) Keratohyalin granules are clearly
visible in normal control skin after H&E staining. Immunohistochemical
staining detects filaggrin repeats readily in 4–5 granular cell layers and
throughout the stratum corneum. (b) The presence of a heterozygous
7945delA FLG mutation in patient 3 leads to reduced keratohyalin
granules and filaggrin staining in the granular layer. The stratum corneum
is also thickened. Patients 2, 4, and 5 show similar histochemical features.
(c) Patient 8, who is a compound heterozygote for 441delA/1249insG
FLG mutations, has barely detectable keratohyalin granules and filaggrin
staining in the granular layer. The stratum corneum is severely thickened.
Patient 6 shows similar histochemical features. Bars¼50 mm.
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suggests that this mutation may be present at low levels in
some Asian populations. Ideally, all detected mutations thus
far should be screened in different population samples to
achieve a more complete picture of the FLG mutations in
different ancestral groups, but this can be time consuming
unless high-throughput screening methods for each mutation
can be developed.
Among the eight IV cases studied, patients 5 and 8 are
compound heterozygotes for FLG mutations and immuno-
histochemical analysis of skin biopsies showed filaggrin to
be nearly absent in the granular layer, whereas patients 2, 3,
4, and 6 who are heterozygous for FLG mutations showed
reduced filaggrin staining compared with the control
(Figure 2). In view of this, it is clearly useful to stain
the skin biopsies, when available, for filaggrin to predict
the likely number of filaggrin mutations carried by an IV
patient. However, it has become apparent that all premature
termination codon mutations in FLG lead to destabilization of
profilaggrin, as observed with human mutations (Sandilands
et al., 2007). Thus, it is not possible to carry out precise
quantification of the amount of filaggrin repeats in the
epidermis of a patient and use this information as a predictive
tool to pinpoint the location of mutations along the FLG gene.
Immunohistochemical studies of skin biopsy from
patient 1 revealed normal levels of filaggrin; therefore, it
was not surprising that no FLG mutations were detected.
As IV and X-linked ichthyosis share similar clinical manifes-
tations (Cuevas-Covarrubias et al., 1998) and this patient is
male, we considered the possibility that this individual might
harbor a mutation in the steroid sulfatase gene (Shapiro et al.,
1978). Subsequently, all 10 exons of the steroid sulfatase
gene were fully sequenced but no mutation was identified,
thus excluding X-linked ichthyosis. Upon further investiga-
tion of the family history, the patient’s daughter was found to
be similarly affected, suggestive of dominant inheritance.
This family therefore appears to have a form of ichthyosis
clinically similar to IV, but where immunohistochemical and
molecular analysis tend to exclude a filaggrin defect.
Patient 7 exhibited a severe IV phenotype and showed
complete absence of filaggrin staining, but no mutation was
detected in the exon 3. Further re-sequencing also confirmed
that the patient had no detectable mutations in exons 1, 2, or
Normal codons 145–149
Normal codons 414–418
Normal codons 2647–2651
R E T G G
R
R S S A G R S R S
delA
G G G insGR RG S S
R E ER
delA
441delA heterozygote 441delA mutant clone
7945delA heterozygote
1249insG heterozygote
7945delA mutant clone
1249insG mutant clone
a
b
c
Figure 3. Frameshift mutations of patients with IV. (a) Direct DNA sequencing of specific FLG PCR products. Left panel shows the normal control
sequence from the FLG S100 domain corresponding to codons 145–149. Middle panel shows the detection of a heterozygous 441delA mutation in patient 8.
Right panel confirms the 441delA mutation by cloning and sequencing of the mutant allele. (b) Left panel shows the normal control sequence from FLG
partial repeat (‘‘repeat 0’’) corresponding to codons 414–418. Middle panel shows the identification of a heterozygous 1249insG mutation detected in
patients 6 and 8. Right panel confirms the 1249insG mutation by cloning and sequencing of the mutant allele. (c) Left panel shows the normal control
sequence from FLG repeat 7 corresponding to codons 2647–2651. Middle panel shows the detection of a heterozygous 7945delA mutation detected in
patient 6. Right panel confirms the 7945delA mutation by cloning and sequencing of the mutant allele.
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the splice sites. Thus, it is possible that patient 7 has a
mutation in another unknown gene that plays a critical role in
the regulation of filaggrin expression, although we also feel it
is possible that a mutation has been missed due to the size
and complexity of this repetitive gene.
Our study brings the total number of FLG mutations
reported to date to twenty. The reason why FLGmutations are
so prevalent is unclear although it has been proposed that
balancing selection conferring a heterozygote advantage
might explain the persistence and independent emergence
of FLG-null mutations in different populations (Nomura et al.,
2007; Sandilands et al., 2007). It has also been speculated
that in individuals carrying one or more FLG-null mutation,
‘‘natural vaccination’’ may have permitted the better survival
of such heterozygotes during ancient pandemics, due to
a stronger background immunity built up by increased
trans-epidermal transfer of pathogenic antigens (Irvine and
McLean, 2006). Further work on animal models carrying
FLG-null mutations will be essential to validate this point.
With the emergence of so many different FLG-null
mutations, more genetic studies on larger numbers of patients
will allow us to identify mutation hotspots. Some mutations
may also deserve closer examination to study any possible
effects on disease penetrance. Current studies report
no difference in phenotype between IV patients with FLG
mutations located in different repeats, but decreased
penetrance in AD susceptibility has been reported for certain
FLG-null mutations (Sandilands et al., 2007). Further FLG
mutation analysis in different populations will allow us to
uncover the full spectrum of mutations and assess their
contributions to skin disease and healthcare globally.
MATERIALS AND METHODS
Clinical material
Blood samples were obtained from eight independent Singaporean
Chinese patients diagnosed with IV and genomic DNA was isolated
according to standard procedures. Skin biopsies (3-mm) from the
patients were also embedded in formalin and sectioned for immuno-
histochemistry analysis. In all cases, we followed the Singapore
Institutional Review Board/Domain Specific Review Board
guidelines, which are in full accordance with the Declaration of
Helsinki Principles, and obtained informed written consent from the
participants or their parents where the patients were below 21 years
of age. DNA from 100 Singaporean and 164 Chinese anonymous,
unselected population controls were also included in the study.
Filaggrin genotyping
FLG mutation analysis and allele size variant determination by
comprehensive screening of FLG in these IV patients was performed
using primers and conditions that have been previously reported
(Sandilands et al., 2007). Further specific details are available
on request. All PCR products were sequenced using an ABI PRISM
3730 genetic analyzer (Applied Biosystems, Foster City, CA).
Mutation E2422X was also screened by restriction digestion as
reported previously (Sandilands et al., 2007). Previously unreported
mutations were confirmed with additional screening methods.
High-throughput screening for 441delA, 1249insG, and
7945delA
To enable high-throughput screening for the three mutations on
control samples, a multiplex fluorescent PCR was used. 50ng of DNA
was amplified in a 10-ml reaction with 1.5mM MgCl2, 0.25mM of each
dNTP, 5 pmol forward primer, 5 pmol reverse primer, 4% (v/v)
DMSO, and 0.5U AmpliTaq Gold polymerase (Applied Biosystems).
The primers used to screen for each mutation and PCR conditions are
listed in Table 1. The combined PCR products were diluted 1:60 and
sized against ROX-500 size markers according to the manufacturer’s
recommended protocol (Applied Biosystems). Expected sizes for
wild-type and mutant alleles are listed in Table 1.
Mutation screening for Q2417X
The Q2417X mutation creates an additional BfaI restriction. A 185-bp
PCR product was amplified in a 25-ml reaction containing 1.5mM
MgCl2, 10pmol forward primer 5
0-CCACACGTGGCCGGTCAGCA-30,
10pmol reverse primer 50-GTCCTGACCCTCTTGGGACGT-30,
0.25mM of each dNTP, 4% (v/v) DMSO, and 1U high-fidelity
polymerase mix (Roche, Penzberg, Germany). PCR amplification
conditions were as follows: one cycle of 94 1C (5minutes) followed by
35 cycles of 94 1C (30 seconds), 64 1C (30 seconds), 72 1C (45 seconds),
Normal codons 2415–2419
L Y Q V S L Y
HTSQEHT
G H R G R G H
Normal codons 2420–2424
Normal codons 4305–4309
Q2417X heterozygote
E2442X heterozygote
R4307X heterozygote
a
b
c
Figure 4. Nonsense mutations of patients with IV. (a) Direct DNA
sequencing of specific FLG PCR products. Left panel shows the normal
control sequence from the FLG repeat 6 corresponding to codons 2415–2419.
Right panel shows a heterozygous transition 7249C4T resulting in nonsense
mutation Q2147X in patient 6. (b) Left panel shows the normal control
sequence from FLG repeat 6 corresponding to codons 2420–2424. Right
panel shows a heterozygous transversion 7264G4T resulting in nonsense
mutation E2422X in patient 4. (c) Left panel shows the normal control
sequence from FLG repeat 10.2 corresponding to codons 4305–4309.
Right panel shows a heterozygous transition 12919C4T resulting in
nonsense mutation R4307X in patient 2.
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and a final extension cycle of 72 1C (5minutes). A 5-ml volume of PCR
product was incubated with 2.5U of BfaI (New England Biolabs,
Ipswich, MA) in a 20-ml reaction volume at 37 1C overnight and
resolved on 3% (w/v) agarose gels. The wild-type allele resolved as an
uncut 185-bp fragment, whereas the mutant allele gave fragments of
132 and 53bp.
Mutation detection and screening for R4307X
100ng of DNA was amplified in a 25-ml reaction containing 1.5mM
MgCl2, 10 pmol forward primer 5
0-CTCATCATGCAGAGAATTCCT
CTG-30, 10 pmol reverse primer 50-CTCCAGTACTGGGCCCAGC-30,
0.25mM of each dNTP, 4% (v/v) DMSO, and 1U of high-fidelity
enzyme (Roche). PCR amplification conditions were as follows:
one cycle of 94 1C (5minutes) followed by 35 cycles of 94 1C
(30 seconds), 58 1C (30 seconds), 72 1C (45 seconds), and a final
extension cycle of 72 1C (5minutes). Mutation R4307X creates an
additionalDdeI site; 5 ml of PCR product was incubated with 2.5U of
DdeI (New England Biolabs) in a 20-ml reaction volume at 37 1C
overnight and resolved on 3% (w/v) agarose gels. The wild-type
allele resolved as 172, 140, 102, and 36-bp fragments, whereas the
mutant allele gave fragments of 172, 140, 51, 51, and 36 bp.
Steroid sulfatase mutation analysis
All exons of the steroid sulfatase gene were amplified by PCR and
directly sequenced using the previously reported methods (Liao
et al., 2007).
Immunohistochemistry
Immunoperoxidase staining of paraffin-embedded sections with the
Envision system (DakoCytomation, Hamburg, Germany) used the
mouse monoclonal 15C10 antibody (Novocastra, Newcastle, UK),
which binds to an epitope in the C-terminal portion of the human
filaggrin repeat unit. Antigen retrieval was performed by heating
sections under pressure for 10–15minutes in 10mmol l1 citrate
buffer, pH 6. Normal skin samples were stained as controls.
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Table 2. FLG profiles of eight Singaporean Chinese IV patients
Patient IV severity
Staining of filaggrin
repeats
Mutation(s)
detected
Repeat
Number
Ethnicity of other cases
where found
1 Severe Normal — — NA
2 Severe Reduced R4307X 10.2 —
3 Mild Reduced 7945delA 7 —
4 Mild Reduced E2422X 6 Dutch, Chinese
5 Severe Nearly absent 1249insG,
7945delA
0, 7 —
6 Severe Reduced Q2417X 6 —
7 Severe Absent — — NA
8 Severe Nearly absent 441delA,
1249insG
S100 domain,
0
—
FLG, filaggrin gene; IV, ichthyosis vulgaris; NA, not available.
Table 1. Primers and conditions for FLG mutation screening by fluorescent PCR
Mutation Primer pairs Label
Annealing
temperature (1C)
Wild-type
allele (bp)
Mutant
allele (bp)
441delA Forward 50-GTTTCTTGCTGATAATGTGATTCTGTCT-30
Reverse 50-ACTAGATTCATGCCTTTTCCC-30
HEX 58 390 389
1249insG Forward 50-GTTTCTTGGGCAAGCTTCATCTGCAGTC-30
Reverse 50-CTTGGTGGCTCTGCTGTCTCA-30
FAM 62 156 157
7945delA Forward 50-GTTTCTTCCCAGGACAAGCAGGAACT-30
Reverse 50-GTCTTCTGAATGTCCCTCAT-30
FAM 60 441 440
FLG, filaggrin gene.
Note: The sequence GTTTCTT was added to the unlabeled forward primer to promote plus-A addition for easier allele calling.
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SUPPLEMENTARY MATERIAL
Figure S1. Hyperlinearity observed in IV patients at low magnification.
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